AWP OVERSTATES ACTUAL PHARMACY INVOICE COST FOR BRAND NAME DRUGS BY AVERAGE OF 18.3% NATIONWIDE, HHS IG CONCLUDES; GENERIC AWP OVERSTATES COST BY 42.5%
Executive Summary
Average wholesale price overstates actual pharmacy acquisition costs for brand name drugs by 18.3%, the HHS Inspector General's Office has concluded based on an audit of state Medicaid payment rates.